The Philippines Is Doubling Its TB Budget. Here Is Why That Matters | APMARGIN
Health Policy

The Philippines Is Doubling Its TB Budget. Here Is Why That Matters

June 8, 2026

Tuberculosis kills an estimated 98 Filipinos every day, making it one of the deadliest diseases in the country despite being preventable and curable. The Department of Health is now backing an ambitious response: screen 12 million Filipinos for TB by the end of 2026, supported by a budget nearly double what was allocated the year before.

The Scale of the Commitment

Under the newly approved Philippine Strategic TB Elimination Plan Phase 2, covering 2025 through 2030, the Department of Health proposed a 4.2 billion peso budget for TB services in the 2026 National Expenditure Program. That is nearly double the 2.6 billion pesos allocated in 2025, and it reflects a directive from President Ferdinand Marcos Jr. to intensify both prevention and treatment efforts nationwide.

12M Filipinos targeted
for screening in 2026
₱4.2B Proposed 2026
TB services budget
98 Estimated Filipino
lives lost daily to TB
6.8% Of global TB cases
occur in the Philippines

The scale of the burden explains the urgency. The Philippines accounts for roughly 6.8 percent of the world's TB cases, equivalent to 625 Filipinos developing the disease for every 100,000 people in the population, the third highest national share in the world after India and Indonesia. Globally, TB remains the world's leading infectious killer, claiming an estimated 1.23 million lives in 2024 alone.

New Tools Are Changing How TB Is Found and Treated

Two technological shifts are central to the plan. The first is the use of ultra-portable, AI-assisted chest X-ray units that allow health workers to screen for TB in communities rather than requiring patients to travel to a hospital, paired with WHO-recommended Nucleic Acid Amplification Tests that confirm diagnoses quickly. These tools are already deployed in the Cordillera Administrative Region as an early rollout site, bringing detection closer to where people actually live.

The second shift addresses one of the hardest parts of TB control: treatment adherence for drug-resistant cases. A new all-oral regimen for multidrug-resistant TB has cut treatment time from two years to six months. Long treatment courses have historically been one of the main reasons patients drop out of care before being cured, so a shorter, fully oral regimen removes a major barrier to completion.

Why Screening Targets Matter More Than They Sound

A target of 12 million screenings might read as an abstract number, but it represents a fundamental shift from passive to active case finding. TB is often called a silent disease because many infected individuals do not develop symptoms severe enough to seek care on their own, allowing transmission to continue undetected. Active, large-scale screening finds those cases earlier, which both improves individual outcomes and reduces community transmission.

The plan also reflects a modest but real recent gain. The current TB death toll marks a 3 percent reduction in mortality from the previous year, a small step but one that health officials view as evidence that current strategies are beginning to work, not as cause for easing them.

A Partnership Built Around Sustained Funding

The World Health Organization has positioned itself as a continuing partner in this effort, supporting the Department of Health at both the national and subnational level.

We know what works, and we're seeing some encouraging results here in the Philippines.

That assessment came from Dr. Eunyoung Ko, Acting WHO Representative to the Philippines, who framed the partnership around three pillars: strengthening case-finding, expanding access to preventive medicines for people exposed to TB, and helping people already diagnosed stick with their treatment plans through to completion. Guimaras has been highlighted as one of the local government areas furthest along in this effort, aiming to become the country's first TB-free island, illustrating that national targets are intended to be matched by province and city level execution rather than centralized delivery alone.

Funding Alone Has Never Been the Missing Piece

A doubled budget and a 12 million person screening target are significant on their own, but the more important signal is what they are funding. AI-assisted portable X-rays and shortened drug-resistant treatment regimens are not incremental tweaks. They directly target the two weakest points in past TB strategies: finding cases that would otherwise go undiagnosed, and keeping patients in treatment long enough to be cured.

The Philippines carries one of the heaviest TB burdens in the world, and meeting that burden has always required more than awareness campaigns. It requires sustained funding translated into tools that reach people where they live. The next year will show whether the 2026 expenditure follows through on what has been proposed.


References

  1. World Health Organization Philippines. WHO, DOH Target 12M Filipinos to be screened for Tuberculosis by 2026; Philippines aims to double budget for TB Services. 12 November 2025.
  2. Philippine News Agency. DOH, WHO target 12M Filipinos to be screened for TB by 2026. 13 November 2025.
  3. Department of Health. Philippine Strategic TB Elimination Plan Phase 2 (PhilSTEP2), 2025-2030.
  4. World Health Organization. Global Tuberculosis Report, 2024 data.
  5. Philstar.com. Philippines has 3rd highest TB cases worldwide. 14 November 2025.
about author - APMARGIN

APMARGIN is a trusted public health consulting firm in the Philippines, delivering research, evaluations, capacity building, technical assistance, and innovative solutions to strengthen health systems and empower communities nationwide.

LATEST POSTS:

Asia Pacific Management and Research Group, Inc. (APMARGIN) 
Unit 202 Metrover Building, McArthur Hi-way, Poblacion, Guiguinto, Bulacan 3015

Copyright © 2026. APMARGIN All Rights Reserved.